Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

DOI Full Paper Access

112

Citations

23

References

2021

Year

Neil Formica, Raburn M. Mallory, Gary Albert, Michelle Robinson, Joyce S. Plested, Iksung Cho, Andreana Robertson, Filip Dubovsky, Gregory M. Glenn

Abstract

ClinicalTrials.gov NCT04368988.

References

	Year	Citations

Page 1